GCP
CRBU icon

GSA Capital Partners’s Caribou Biosciences CRBU Stock Holding History

GSA Capital Partners’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$913K Buy
480,724
+109,352
+29% +$188K 0.06% 535
2025
Q4 		$590K Buy
+371,372
New +$779K 0.05% 705
2025
Q3 		– Sell
-166,396
Closed -$210K – 1716
2025
Q2 		$210K Buy
166,396
+148,791
+845% +$146K 0.01% 1485
2025
Q1 		$16K Buy
+17,605
New +$22.9K ﹤0.01% 1588
2023
Q4 		– Sell
-10,734
Closed -$51K – 1551
2023
Q3 		$51K Buy
+10,734
New +$66.6K ﹤0.01% 1415
2022
Q3 		– Sell
-14,917
Closed -$81K – 1571
2022
Q2 		$81K Sell
14,917
-10,104
-40% -$77.2K 0.01% 1246
2022
Q1 		$230K Buy
+25,021
New +$264K 0.03% 1084

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return